新五丰：2025年前三季度净利润约-1317万元

Group 1 - New Wufeng reported a revenue of approximately 5.39 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 2.27% [1] - The net profit attributable to shareholders of the listed company was a loss of approximately 13.17 million yuan [1] - As of the report date, New Wufeng's market capitalization was 8 billion yuan [2] Group 2 - The Chinese innovative drug sector has sold overseas authorizations worth 80 billion US dollars this year [2] - The secondary market for biomedicine is experiencing a boom, while the primary market is facing challenges in fundraising [2]